20
Biophore India Pharmaceuticals Pvt Ltd, based in India, is a pharmaceutical company that stands out with its certifications from EDQM.
They are recognized for Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
One of their notable products is TAVABOROLE, with a corresponding US DMF Number 31431.
Remarkably, this DMF maintains an Active status since its submission on March 02, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 17, 2017, and payment made on March 13, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II